Anticancer Drugs Course
This Anticancer Drugs Course equips oncology professionals with practical skills to manage first-line EGFR TKI therapies for EGFR-mutated NSCLC. Learners will master treatment selection using current evidence, toxicity prevention and control strategies, resistance assessment through imaging and biopsies, second-line planning, and effective patient communication to improve outcomes and build confidence in evidence-based decisions.

from 4 to 360h flexible workload
valid certificate in your country
What will I learn?
Gain a practical overview of first-line systemic treatments for EGFR-mutated NSCLC, covering targeted therapies, chemo-immunotherapy, and chemotherapy. The course details drug mechanisms, dosing schedules, toxicity profiles, prevention tactics, management approaches, resistance mechanisms, second-line choices, monitoring protocols, and communication skills for assured, evidence-driven patient care.
Elevify advantages
Develop skills
- Select EGFR TKI treatments based on latest trial data for first-line use.
- Plan imaging, re-biopsy, and liquid biopsy to address resistance.
- Align second-line options with resistance using targeted therapy, chemo, or trials.
- Prevent and handle EGFR TKI side effects like rash, diarrhoea, ILD, and low blood counts.
- Counsel patients clearly on treatment aims, effects, and next steps.
Suggested summary
Before starting, you can change the chapters and workload. Choose which chapter to start with. Add or remove chapters. Increase or decrease the course workloadWhat our students say
FAQs
Who is Elevify? How does it work?
Do the courses have certificates?
Are the courses free?
What is the course workload?
What are the courses like?
How do the courses work?
What is the duration of the courses?
What is the cost or price of the courses?
What is an EAD or online course and how does it work?
PDF Course